Search
Volinanserin
go.drugbank.com/drugs/DB16351InvestigationalVolinanserin is under investigation in clinical trial NCT00464243 (Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study).
PV903
go.drugbank.com/drugs/DB05163ExperimentalPV903 is a self administered vaginally delivered recombinant protein for the treatment of recurrent miscarriage, resulting from an intolerant immune response to the developing foetus.
SUVN-502
go.drugbank.com/drugs/DB06140Investigationalpotent, safe, highly selective and orally active antagonist at a central nervous system serotonin receptor site 5-HT6 intended for treatment of cognitive disorders such as Alzheimer’s and Schizophrenia, an
BZL101
go.drugbank.com/drugs/DB05051InvestigationalBZL101 is an oral drug designed for the treatment of advanced breast cancer with a novel mechanism of action. BZL101 targets diseased cells while leaving normal cells healthy and intact.
AZD 3355
go.drugbank.com/drugs/DB05404InvestigationalIt is developed by AstraZeneca and is currently in phase I/II trials.
Seproxetine
go.drugbank.com/drugs/DB06731ExperimentalIt is an active metabolite of fluoxetine. Seproxetine was being investigated by Eli Lilly as an antidepressant but development was never completed and the drug was never marketed.
Dextrorphan
go.drugbank.com/drugs/DB14682ExperimentalSynonyms: (+)-N-methylmorphinan-3-ol, d-3-hydroxy-N-methylmorphinanCategories: Compounds used in a research, industrial, or household settingCepharanthine
go.drugbank.com/drugs/DB16824InvestigationalCategories: Compounds used in a research, industrial, or household settingTetramethrin
go.drugbank.com/drugs/DB13752ExperimentalCategories: Compounds used in a research, industrial, or household setting